["{\n\"step_by_step_thinking\": \"The relevant documents discuss non-steroidal anti-inflammatory drugs (NSAI) potentiating the antithrombotic efficacy of low molecular weight heparin (LMWH). Additionally, there is no mention of NSAI drugs being used to treat cancer associated thromboembolism. Therefore, we should look for other options in the choices provided that are related to cancer treatment and thromboembolism.\",\n\"answer_choice\": \"D\""]